search
Back to results

Support-t Online Training in Youth Living With Type 1 Diabetes Transitioning to Adult Care (Support-t)

Primary Purpose

Diabetes Mellitus, Diabetes Mellitus, Type 1, Glucose Metabolism Disorders (Including Diabetes Mellitus)

Status
Not yet recruiting
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Support-t
Sponsored by
McGill University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Diabetes Mellitus focused on measuring Transition Care, Pediatric, Adolescent, Education, Hemaglobin A1c, Self-management, Randomized Controlled Trial

Eligibility Criteria

14 Years - 16 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Adolescents with a clinical diagnosis of T1D 14-16 years of age Receiving diabetes care at one of 4 university teaching hospital-based pediatric diabetes clinics in Quebec: Montreal Children's Hospital-McGill University Health Centre, Centre hospitalier universitaire de Sherbrooke, Le Copain-Hôpital de Gatineau, Centre Hospitalier Universitaire de Québec Having access to internet Having an active email address Fluent in English or French Exclusion Criteria: Severe neurocognitive disabilities Patients with conditions associated with shortened erythrocyte survival, such as hemolytic anemia or other conditions associated with inaccurate HbA1c

Sites / Locations

  • Clinique de pédiatrie Le Copain-Hôpital de Gatineau
  • Montreal Children's Hospital - McGill University Health Centre
  • Centre Hospitalier Universitaire de Québec
  • Centre Hospitalier Universitaire de Sherbrooke

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Support-t plus usual diabetes care

Usual diabetes care only

Arm Description

Access to the Support-t online training and peer support platform in addition to usual diabetes care for 18 months. Support-t contains 3 components: 1) Educational material, 2) News blog and 3) Patients' discussion forum. Health care providers from the pediatric diabetes clinics will receive Support-t training and will be encouraged to recommend the Support-t platform during routine care with their patients from the active arm.

Usual diabetes care for 18 months, which consists of visits with their health care provider and ad-hoc diabetes education with nurses and dietitians. Health care providers from the pediatric diabetes clinics will be instructed not to discuss or refer to the Support-t platform with patients from the control arm. Control arm participants will have the option to use the Support-t platform after the 18-month study.

Outcomes

Primary Outcome Measures

Change from Baseline Hemaglobin A1c (HbA1c) at 18 months
HbA1c measured with a venous or capillary blood sample as part of the standard of diabetes care will be derived from the medical record chart or measured using an A1c Test Kit, which is a non-fasting, finger prick, whole blood test

Secondary Outcome Measures

Change from Baseline Hemaglobin A1c (HbA1c) at 6 and 12 months
HbA1c measured with a venous or capillary blood sample as part of the standard of diabetes care will be derived from the medical record chart or measured using an A1c Test Kit, which is a non-fasting, finger prick, whole blood test
Continuous Glucose Monitoring (CGM) - % Time in range
% Time in range (3.9-10.0mmol/L) over the past 4 weeks will be derived from the medical record chart
Continuous Glucose Monitoring (CGM) - % Time above range
% Time above range (3.9-10.0mmol/L) over the past 4 weeks will be derived from the medical record chart
Continuous Glucose Monitoring (CGM) - % Time below range
% Time below range (3.9-10.0mmol/L) over the past 4 weeks will be derived from the medical record chart
Continuous Glucose Monitoring (CGM) - Standard deviation
Standard deviation of the past 4 weeks will be derived from the medical record chart
Continuous Glucose Monitoring (CGM) - % Coefficient of variation
% Coefficient of variation of the past 4 weeks will be derived from the medical record chart
Severe hypoglycemic events
Any severe hypoglycemic events in the past 6 months will be derived from self-report and from the medical record chart
Diabetic Ketoacidosis (DKA) events
Any Diabetic Ketoacidosis (DKA) events in the past 6 months will be derived from self-report and from the medical record chart
Diabetes-related hospitalizations
Any diabetes-related hospitalizations in the past 6 months, expressed as number of hospitalizations per person-years (P-Y) at risk will be derived from self-report and from the medical record chart
Diabetes-related emergency department visits
Any diabetes-related emergency-department visits in the past 6 months, expressed as number of emergency department visits per person-years (P-Y) at risk will be derived from self-report and from the medical record chart
Self-efficacy
Self-efficacy for Diabetes Self-Management Measure (SEDM) assesses self-efficacy. The score ranges from 1 to 10. All item scores are averaged to compute the score. A higher score represents a better outcome.
Diabetes distress
Problem Areas in Diabetes Scale-Teen (PAID-T) assesses adolescent diabetes distress. The scores range from 14 to 84. A total distress score is computed by summing responses. Higher scores indicate youth perception of feeling more burdened related to T1D.
Diabetes specific Quality of Life (QOL)
Type 1 Diabetes and Life (T1DAL) questionnaire assesses diabetes specific QOL for 12-17 year old adolescents living with T1D. Scores are transformed on a scale from 0 to 100. The total score ranges from 0 to 100. To calculate the total score, the mean is computed as the sum of all item scores divided by the number of items answered on all the scales. A higher total score represents a better outcome. The subscale scores (Daily Emotional Experiences & Daily Activities, Handling Diabetes Well, Peer Relationships, and Family Relationships) range from 0 to 100. To calculate the subscale scores, the mean is computed as the sum of the items in the subscale divided by the number of items answered on the subscale. Higher subscale scores represent a better outcome.
Transition readiness
Readiness Assessment of Emerging Adults with Type 1 Diabetes Diagnosed in Youth (READDY) assesses diabetes-related knowledge or skill items by querying respondents on 42 total items split into 5 domains: knowledge, navigation, health behaviors, and insulin pump skills. Respondents answer on a Likert scale from "yes, I can do this" scored 5 to "Haven't thought about it" scored 1. Confidence level is evaluated in each domain with a higher score indicating more confidence.
Cost effectiveness (HbA1c)
Cost effectiveness of access to Support-t in addition to usual care compared with usual care in terms of incremental cost effectiveness ratio (ICER) for HbA1c
Cost effectiveness (self-efficacy)
Cost effectiveness of access to Support-t in addition to usual care compared with usual care in terms of incremental cost effectiveness ratio (ICER) for self-efficacy
Cost effectiveness (diabetes distress)
Cost effectiveness of access to Support-t in addition to usual care compared with usual care in terms of incremental cost effectiveness ratio (ICER) for diabetes distress
Cost effectiveness (QOL)
Cost effectiveness of access to Support-t in addition to usual care compared with usual care in terms of incremental cost effectiveness ratio (ICER) for QOL

Full Information

First Posted
June 6, 2023
Last Updated
July 10, 2023
Sponsor
McGill University
Collaborators
McGill University Health Centre/Research Institute of the McGill University Health Centre, Centre de recherche du Centre hospitalier universitaire de Sherbrooke, CSSS de Gatineau, CHU de Quebec-Universite Laval
search

1. Study Identification

Unique Protocol Identification Number
NCT05910840
Brief Title
Support-t Online Training in Youth Living With Type 1 Diabetes Transitioning to Adult Care
Acronym
Support-t
Official Title
Support-t, an Online Training and Peer Support Platform to Accompany Youth Living With Type 1 Diabetes Transitioning to Adult Healthcare
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
November 1, 2023 (Anticipated)
Primary Completion Date
December 31, 2026 (Anticipated)
Study Completion Date
June 1, 2027 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
McGill University
Collaborators
McGill University Health Centre/Research Institute of the McGill University Health Centre, Centre de recherche du Centre hospitalier universitaire de Sherbrooke, CSSS de Gatineau, CHU de Quebec-Universite Laval

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The investigators will conduct a randomized controlled trial (RCT) to examine how an online training and peer support platform could help the preparation to transition to adult care. Among 14-16 year old youth with Type 1 Diabetes (T1D), the investigators aim to assess the effect of an online training and peer support platform (Support-t) integrated in usual care, compared with usual care on Hemoglobin A1c (HbA1c), adverse outcomes and psychosocial measures during the preparation for transition to adult care. The investigators will conduct a multi-site, parallel group, blinded (outcome assessors, data analysts), superiority RCT of adolescents with T1D (14-16 years of age) followed at one of 4 university teaching hospital-based pediatric diabetes clinics in the province of Quebec.
Detailed Description
The transition from pediatric to adult diabetes care is a challenging period for adolescents and young adults living with chronic conditions, such as Type 1 Diabetes (T1D). For youth with T1D, transition from pediatric to adult care is characterized by deterioration in glycemic control (Hemoglobin A1c [HbA1c]), reduced adherence to diabetes management tasks and increased risk of diabetes complications. The investigators propose to examine an online training and peer support platform as a potential alternative for delivering transition care. In adolescents with T1D, the investigators hypothesize that an online training and peer support platform (Support-t), when integrated into usual pediatric care, as compared with usual care alone, will result in better HbA1c, less adverse outcomes and better psychosocial outcomes during the preparation for transfer to adult care. Primary Aim: To determine the impact of adding access to Support-t to usual care compared with usual care alone, on HbA1c during the preparation for transfer to adult care. Secondary Aims: To determine the impact of adding access to Support-t to usual care compared with usual care alone, on self-efficacy, diabetes distress, quality of life (QOL; diabetes specific), readiness to transfer to adult care, glucose management, severe hypoglycemic episodes, diabetic ketoacidosis (DKA), T1D-related ED-visits and hospitalizations during the preparation for transfer to adult care. 2. To determine the cost-effectiveness of Support-t. 3. To understand the context for implementation in regards to level of engagement on Support-t, satisfaction and experience (barriers, facilitators) with Support-t. Methods: The investigators will conduct a multi-site, parallel group, blinded (outcome assessors, data analysts), superiority RCT of adolescents with T1D (14-16 years of age) followed at one of 4 university teaching hospital-based pediatric diabetes clinics in Quebec. Patients will be recruited over 20 months. Interventions will occur over 18 months. Follow-up will be to 18 months from enrollment. Allocation will be concealed with a 1:1 intervention to control ratio. Participants in the active arm will have access to a mobile-based online training and peer support platform (Support-t) added to usual care. Participants in the control group will have in parallel with the intervention group, their usual diabetes care. The primary outcome is the change in HbA1c measured at 18 months (HbA1c measured at 18 months - HbA1c measured at baseline). Secondary outcomes are self-efficacy, diabetes distress, QOL, readiness to transfer, glucose management, severe hypoglycemic episodes, DKA, T1D-related ED-visits and hospitalizations. Assessments are at baseline, 6, 12 and 18 months. Analysis will be by intention-to-treat. Outcomes will be calculated and compared between the 2 trial arms using differences with 95% Confidence Intervals, along with a cost-effectiveness analysis. Interviews will be conducted to analyze the context for implementation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes Mellitus, Diabetes Mellitus, Type 1, Glucose Metabolism Disorders (Including Diabetes Mellitus), Metabolic Disease, Endocrine System Diseases, Autoimmune Diseases, Immune System Diseases
Keywords
Transition Care, Pediatric, Adolescent, Education, Hemaglobin A1c, Self-management, Randomized Controlled Trial

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Active arm: Participants randomized to the active arm will have access to the Support-t online training and peer support platform in addition to their usual diabetes care, over the 18 month intervention period. Support-t contains 3 components: 1) Educational material, 2) News blog and 3) Patients' discussion forum. Control arm: Participants randomized to usual care only will attend their usual diabetes clinic visits, over the 18-month intervention period, which consists of visits with their health care provider and ad-hoc diabetes education with nurses and dietitians.
Masking
Outcomes Assessor
Masking Description
Data analysts
Allocation
Randomized
Enrollment
200 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Support-t plus usual diabetes care
Arm Type
Experimental
Arm Description
Access to the Support-t online training and peer support platform in addition to usual diabetes care for 18 months. Support-t contains 3 components: 1) Educational material, 2) News blog and 3) Patients' discussion forum. Health care providers from the pediatric diabetes clinics will receive Support-t training and will be encouraged to recommend the Support-t platform during routine care with their patients from the active arm.
Arm Title
Usual diabetes care only
Arm Type
No Intervention
Arm Description
Usual diabetes care for 18 months, which consists of visits with their health care provider and ad-hoc diabetes education with nurses and dietitians. Health care providers from the pediatric diabetes clinics will be instructed not to discuss or refer to the Support-t platform with patients from the control arm. Control arm participants will have the option to use the Support-t platform after the 18-month study.
Intervention Type
Other
Intervention Name(s)
Support-t
Intervention Description
Support-t plus usual diabetes care for 18 months
Primary Outcome Measure Information:
Title
Change from Baseline Hemaglobin A1c (HbA1c) at 18 months
Description
HbA1c measured with a venous or capillary blood sample as part of the standard of diabetes care will be derived from the medical record chart or measured using an A1c Test Kit, which is a non-fasting, finger prick, whole blood test
Time Frame
18 months
Secondary Outcome Measure Information:
Title
Change from Baseline Hemaglobin A1c (HbA1c) at 6 and 12 months
Description
HbA1c measured with a venous or capillary blood sample as part of the standard of diabetes care will be derived from the medical record chart or measured using an A1c Test Kit, which is a non-fasting, finger prick, whole blood test
Time Frame
6, 12 months
Title
Continuous Glucose Monitoring (CGM) - % Time in range
Description
% Time in range (3.9-10.0mmol/L) over the past 4 weeks will be derived from the medical record chart
Time Frame
0, 6, 12, 18 months
Title
Continuous Glucose Monitoring (CGM) - % Time above range
Description
% Time above range (3.9-10.0mmol/L) over the past 4 weeks will be derived from the medical record chart
Time Frame
0, 6, 12, 18 months
Title
Continuous Glucose Monitoring (CGM) - % Time below range
Description
% Time below range (3.9-10.0mmol/L) over the past 4 weeks will be derived from the medical record chart
Time Frame
0, 6, 12, 18 months
Title
Continuous Glucose Monitoring (CGM) - Standard deviation
Description
Standard deviation of the past 4 weeks will be derived from the medical record chart
Time Frame
0, 6, 12, 18 months
Title
Continuous Glucose Monitoring (CGM) - % Coefficient of variation
Description
% Coefficient of variation of the past 4 weeks will be derived from the medical record chart
Time Frame
0, 6, 12, 18 months
Title
Severe hypoglycemic events
Description
Any severe hypoglycemic events in the past 6 months will be derived from self-report and from the medical record chart
Time Frame
0, 6, 12, 18 months
Title
Diabetic Ketoacidosis (DKA) events
Description
Any Diabetic Ketoacidosis (DKA) events in the past 6 months will be derived from self-report and from the medical record chart
Time Frame
0, 6, 12, 18 months
Title
Diabetes-related hospitalizations
Description
Any diabetes-related hospitalizations in the past 6 months, expressed as number of hospitalizations per person-years (P-Y) at risk will be derived from self-report and from the medical record chart
Time Frame
0, 6, 12, 18 months
Title
Diabetes-related emergency department visits
Description
Any diabetes-related emergency-department visits in the past 6 months, expressed as number of emergency department visits per person-years (P-Y) at risk will be derived from self-report and from the medical record chart
Time Frame
0, 6, 12, 18 months
Title
Self-efficacy
Description
Self-efficacy for Diabetes Self-Management Measure (SEDM) assesses self-efficacy. The score ranges from 1 to 10. All item scores are averaged to compute the score. A higher score represents a better outcome.
Time Frame
0, 6, 12, 18 months
Title
Diabetes distress
Description
Problem Areas in Diabetes Scale-Teen (PAID-T) assesses adolescent diabetes distress. The scores range from 14 to 84. A total distress score is computed by summing responses. Higher scores indicate youth perception of feeling more burdened related to T1D.
Time Frame
0, 6, 12, 18 months
Title
Diabetes specific Quality of Life (QOL)
Description
Type 1 Diabetes and Life (T1DAL) questionnaire assesses diabetes specific QOL for 12-17 year old adolescents living with T1D. Scores are transformed on a scale from 0 to 100. The total score ranges from 0 to 100. To calculate the total score, the mean is computed as the sum of all item scores divided by the number of items answered on all the scales. A higher total score represents a better outcome. The subscale scores (Daily Emotional Experiences & Daily Activities, Handling Diabetes Well, Peer Relationships, and Family Relationships) range from 0 to 100. To calculate the subscale scores, the mean is computed as the sum of the items in the subscale divided by the number of items answered on the subscale. Higher subscale scores represent a better outcome.
Time Frame
0, 6, 12, 18 months
Title
Transition readiness
Description
Readiness Assessment of Emerging Adults with Type 1 Diabetes Diagnosed in Youth (READDY) assesses diabetes-related knowledge or skill items by querying respondents on 42 total items split into 5 domains: knowledge, navigation, health behaviors, and insulin pump skills. Respondents answer on a Likert scale from "yes, I can do this" scored 5 to "Haven't thought about it" scored 1. Confidence level is evaluated in each domain with a higher score indicating more confidence.
Time Frame
0, 6, 12, 18 months
Title
Cost effectiveness (HbA1c)
Description
Cost effectiveness of access to Support-t in addition to usual care compared with usual care in terms of incremental cost effectiveness ratio (ICER) for HbA1c
Time Frame
12 and 18 months
Title
Cost effectiveness (self-efficacy)
Description
Cost effectiveness of access to Support-t in addition to usual care compared with usual care in terms of incremental cost effectiveness ratio (ICER) for self-efficacy
Time Frame
12 and 18 months
Title
Cost effectiveness (diabetes distress)
Description
Cost effectiveness of access to Support-t in addition to usual care compared with usual care in terms of incremental cost effectiveness ratio (ICER) for diabetes distress
Time Frame
12 and 18 months
Title
Cost effectiveness (QOL)
Description
Cost effectiveness of access to Support-t in addition to usual care compared with usual care in terms of incremental cost effectiveness ratio (ICER) for QOL
Time Frame
12 and 18 months
Other Pre-specified Outcome Measures:
Title
Engagement with Support-t platform (T1D patient) - time in minutes on platform
Description
Engagement metrics will be extracted using Google analytics - time (minutes) spent on the platform
Time Frame
6, 12, 18 months
Title
Engagement with Support-t platform (T1D patient) - discussion forum participation
Description
Engagement metrics will be extracted using Google analytics - participation on the platform discussion forum
Time Frame
6, 12, 18 months
Title
Engagement with Support-t platform (T1D patient) - content accessed
Description
Engagement metrics will be extracted using Google analytics - specific content accessed from the platform
Time Frame
6, 12, 18 months
Title
Engagement with Support-t platform (T1D patient) - total pages viewed
Description
Engagement metrics will be extracted using Google analytics - total pages viewed from the platform
Time Frame
6, 12, 18 months
Title
Engagement with Support-t platform (T1D patient) - downloaded documents
Description
Engagement metrics will be extracted using Google analytics - downloaded documents from the platform
Time Frame
6, 12, 18 months
Title
Engagement with Support-t platform (T1D patient) - use of calculators
Description
Engagement metrics will be extracted using Google analytics - use of calculators on the platform
Time Frame
6, 12, 18 months
Title
Engagement with Support-t platform (Health Care Provider) - time in minutes on platform
Description
Engagement metrics will be extracted using Google analytics - time (minutes) spent on the platform
Time Frame
6, 12 months
Title
Engagement with Support-t platform (Health Care Provider) - content accessed
Description
Engagement metrics will be extracted using Google analytics - specific content accessed from the platform
Time Frame
6, 12 months
Title
Engagement with Support-t platform (Health Care Provider) - total pages viewed
Description
Engagement metrics will be extracted using Google analytics - total pages viewed from the platform
Time Frame
6, 12 months
Title
Engagement with Support-t platform (Health Care Provider) - downloaded documents
Description
Engagement metrics will be extracted using Google analytics - downloaded documents from the platform
Time Frame
6, 12 months
Title
Engagement with Support-t platform (Health Care Provider) - use of calculators
Description
Engagement metrics will be extracted using Google analytics - use of calculators on the platform
Time Frame
6, 12 months
Title
Satisfaction with Support-t platform - T1D patient
Description
Satisfaction will be rated on a scale from 1 to 10. Higher scores indicate greater satisfaction with the platform.
Time Frame
6, 12, 18 months
Title
Experience with Support-t platform (Barriers, facilitators, satisfaction, fidelity) - T1D patient
Description
Individual interviews to understand the experience in the context of implementation of the Support-t platform (Barriers, facilitators, satisfaction, fidelity) using qualitative descriptive methodology
Time Frame
18 months
Title
Experience with Support-t platform (Barriers, facilitators, satisfaction, fidelity) - Health Care Provider
Description
Individual interviews to understand the experience in the context of implementation of the Support-t platform (Barriers, facilitators, satisfaction, fidelity) using qualitative descriptive methodology
Time Frame
12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
14 Years
Maximum Age & Unit of Time
16 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adolescents with a clinical diagnosis of T1D 14-16 years of age Receiving diabetes care at one of 4 university teaching hospital-based pediatric diabetes clinics in Quebec: Montreal Children's Hospital-McGill University Health Centre, Centre hospitalier universitaire de Sherbrooke, Le Copain-Hôpital de Gatineau, Centre Hospitalier Universitaire de Québec Having access to internet Having an active email address Fluent in English or French Exclusion Criteria: Severe neurocognitive disabilities Patients with conditions associated with shortened erythrocyte survival, such as hemolytic anemia or other conditions associated with inaccurate HbA1c
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Anne-Sophie Brazeau, PhD
Phone
(514) 398-7848
Email
anne-sophie.brazeau@mcgill.ca
First Name & Middle Initial & Last Name or Official Title & Degree
Amelie Roy-Fleming, MSc
Email
amelie.roy-fleming@mcgill.ca
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Anne-Sophie Brazeau, PhD
Organizational Affiliation
School of Human Nutrition - McGill University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Clinique de pédiatrie Le Copain-Hôpital de Gatineau
City
Gatineau
Country
Canada
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yohan Couture, MD
Email
yohann_couture@ssss.gouv.qc.ca
First Name & Middle Initial & Last Name & Degree
Andréane Vanasse, RN
Email
Andreanne.Vanasse@ssss.gouv.qc.ca
Facility Name
Montreal Children's Hospital - McGill University Health Centre
City
Montréal
Country
Canada
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Meranda Nakhla, MD
Email
meranda.nakhla@mcgill.ca
First Name & Middle Initial & Last Name & Degree
Elise Mok, PhD
Email
elise.mok@affiliate.mcgill.ca
Facility Name
Centre Hospitalier Universitaire de Québec
City
Québec
Country
Canada
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Julie Gagne, MD
Email
gagne.julie.med@ssss.gouv.qc.ca
Facility Name
Centre Hospitalier Universitaire de Sherbrooke
City
Sherbrooke
Country
Canada
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Judith Simoneau-Roy, MD
Email
judith.simoneau-roy@usherbrooke.ca

12. IPD Sharing Statement

Citations:
PubMed Identifier
37156577
Citation
Sanmugalingham G, Mok E, Cafazzo JA, Desveaux L, Brazeau AS, Booth GL, Greenberg M, Kichler J, Rac VE, Austin P, Goldbloom E, Henderson M, Landry A, Zenlea I, Taylor M, Nakhla M, Shulman R. Text message-based intervention, Keeping in Touch (KiT), to support youth as they transition to adult type 1 diabetes care: a protocol for a multisite randomised controlled superiority trial. BMJ Open. 2023 May 8;13(5):e071396. doi: 10.1136/bmjopen-2022-071396.
Results Reference
background
PubMed Identifier
37121571
Citation
Xie LF, Housni A, Nakhla M, Cianci R, Leroux C, Da Costa D, Brazeau AS. Adaptation of an Adult Web Application for Type 1 Diabetes Self-management to Youth Using the Behavior Change Wheel to Tailor the Needs of Health Care Transition: Qualitative Interview Study. JMIR Diabetes. 2023 Apr 26;8:e42564. doi: 10.2196/42564.
Results Reference
background
PubMed Identifier
34967058
Citation
Ladd JM, Reeves-Latour J, Dasgupta K, Bell LE, Anjachak N, Nakhla M. Toward a better understanding of transition from paediatric to adult care in type 1 diabetes: A qualitative study of adolescents. Diabet Med. 2022 May;39(5):e14781. doi: 10.1111/dme.14781. Epub 2022 Jan 7.
Results Reference
background
PubMed Identifier
31719096
Citation
Mok E, Henderson M, Dasgupta K, Rahme E, Hajizadeh M, Bell L, Prevost M, Frei J, Nakhla M. Group education for adolescents with type 1 diabetes during transition from paediatric to adult care: study protocol for a multisite, randomised controlled, superiority trial (GET-IT-T1D). BMJ Open. 2019 Nov 11;9(11):e033806. doi: 10.1136/bmjopen-2019-033806.
Results Reference
background
PubMed Identifier
34176613
Citation
Alwadiy F, Mok E, Dasgupta K, Rahme E, Frei J, Nakhla M. Association of Self-Efficacy, Transition Readiness and Diabetes Distress With Glycemic Control in Adolescents With Type 1 Diabetes Preparing to Transition to Adult Care. Can J Diabetes. 2021 Jul;45(5):490-495. doi: 10.1016/j.jcjd.2021.05.006. Epub 2021 May 19.
Results Reference
background
PubMed Identifier
29577410
Citation
Michaud S, Dasgupta K, Bell L, Yale JF, Anjachak N, Wafa S, Nakhla M. Adult care providers' perspectives on the transition to adult care for emerging adults with Type 1 diabetes: a cross-sectional survey. Diabet Med. 2018 Jul;35(7):846-854. doi: 10.1111/dme.13627. Epub 2018 May 2.
Results Reference
background
PubMed Identifier
37182591
Citation
Lafontaine S, Mok E, Frei J, Henderson M, Rahme E, Dasgupta K, Nakhla M. Associations of Diabetes-related and Health-related Quality of Life With Glycemic Levels in Adolescents With Type 1 Diabetes Preparing to Transition to Adult Care. Can J Diabetes. 2023 Aug;47(6):525-531. doi: 10.1016/j.jcjd.2023.05.002. Epub 2023 May 12.
Results Reference
background
PubMed Identifier
37269172
Citation
Soufi A, Mok E, Henderson M, Dasgupta K, Rahme E, Nakhla M. Association of stigma, diabetes distress and self-efficacy with quality of life in adolescents with type 1 diabetes preparing to transition to adult care. Diabet Med. 2023 Jun 3:e15159. doi: 10.1111/dme.15159. Online ahead of print.
Results Reference
background
PubMed Identifier
26498219
Citation
Wafa S, Nakhla M. Improving the Transition from Pediatric to Adult Diabetes Healthcare: A Literature Review. Can J Diabetes. 2015 Dec;39(6):520-8. doi: 10.1016/j.jcjd.2015.08.003. Epub 2015 Oct 20.
Results Reference
background
PubMed Identifier
19933731
Citation
Nakhla M, Daneman D, To T, Paradis G, Guttmann A. Transition to adult care for youths with diabetes mellitus: findings from a Universal Health Care System. Pediatrics. 2009 Dec;124(6):e1134-41. doi: 10.1542/peds.2009-0041. Epub 2009 Nov 23.
Results Reference
background
PubMed Identifier
18717235
Citation
Nakhla M, Daneman D, Frank M, Guttmann A. Translating transition: a critical review of the diabetes literature. J Pediatr Endocrinol Metab. 2008 Jun;21(6):507-16.
Results Reference
background
PubMed Identifier
28761657
Citation
Nakhla M, Bell LE, Wafa S, Dasgupta K. Improving the transition from pediatric to adult diabetes care: the pediatric care provider's perspective in Quebec, Canada. BMJ Open Diabetes Res Care. 2017 Jun 30;5(1):e000390. doi: 10.1136/bmjdrc-2017-000390. eCollection 2017.
Results Reference
background
PubMed Identifier
33576092
Citation
Robinson ME, Simard M, Larocque I, Shah J, Rahme E, Nakhla M. Psychiatric disorders in emerging adults with diabetes transitioning to adult care: A retrospective cohort study. Diabet Med. 2021 Jun;38(6):e14541. doi: 10.1111/dme.14541. Epub 2021 Feb 19.
Results Reference
background

Learn more about this trial

Support-t Online Training in Youth Living With Type 1 Diabetes Transitioning to Adult Care

We'll reach out to this number within 24 hrs